These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25496985)

  • 1. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
    Sato A; Takano T; Chinushi M; Minamino T
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
    Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
    Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome?
    Ergül Y; Özgür S; Onan SH; Tuzcu V
    Turk Kardiyol Dern Ars; 2018 Dec; 46(8):718-722. PubMed ID: 30516532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
    Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
    Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
    Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
    Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
    Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
    Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
    Nagase S; Kusano KF; Yoshida M; Ohe T
    Heart Rhythm; 2007 Apr; 4(4):512-5. PubMed ID: 17399643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome.
    Ünal Yüksekgönül A; Azak E; Akalın A; Ertuğrul İ; Kılıç E; Utine GE; Karagöz T
    Eur J Med Genet; 2022 Jun; 65(6):104499. PubMed ID: 35429663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
    Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
    Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome.
    Fox DJ; Klein GJ; Hahn A; Skanes AC; Gula LJ; Yee RK; Subbiah RN; Krahn AD
    Europace; 2008 Aug; 10(8):1006-8. PubMed ID: 18621769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
    Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
    Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
    J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
    Rujirachun P; Junyavoraluk A; Pithukpakorn M; Suktitipat B; Winijkul A
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12798. PubMed ID: 32959505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
    Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
    Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.